Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
US8637507B2 · kind B2 · utility
30Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2010 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Sep 28, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase (“DGAT”) inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below: formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.